Kronox Lab Sciences IPO Details, Financials, Valuation & Peers
Get everything you need to know about the Kronox Lab Sciences IPO. Explore Kronox Lab Sciences IPO details, including IPO dates, financial statements, valuation, peer comparison, and more.
Overview
Kronox Lab Sciences Limited is a manufacturer of high-purity specialty fine chemicals, catering to a diverse array of industries. Established as a significant player in the chemical manufacturing sector, the company provides products that serve as essential components in pharmaceuticals, biotech, scientific research, nutraceuticals, agrochemicals, personal care, metallurgy, and animal health. The company’s commitment to quality, product development, and customer satisfaction has positioned it as a preferred supplier both in India and globally.
Key Points:
- Product Offerings:
- High Purity Specialty Fine Chemicals: Used in pharmaceuticals (APIs, excipients), biotech applications, scientific research, nutraceuticals, agrochemicals, personal care products, metal refining, and animal health.
- Product Families: Includes phosphates, sulfates, chlorides, acetates, nitrates, nitrites, citrates, carbonates, EDTA derivatives, hydroxides, succinates, gluconates, and other chemical compounds.
- Product Grades: Manufactured according to various industry standards (IP, BP, EP, JP, USP, FCC, LR, AR, GR, ACS) and custom specifications.
- Product Range:
- Over 185 products spanning across various chemical families.
- Products supplied to customers in India and more than 20 countries worldwide.
- Industry Applications:
- Pharmaceuticals: Excipients, reacting agents, chelating agents, raw materials for APIs.
- Biotech: Buffers, chelating agents, fermentation agents, process intermediates.
- Scientific Research: Drying agents, dehydrating agents, catalysts, complexing agents.
- Nutraceuticals: Ingredients in dietary and health supplements, stabilizers.
- Agrochemicals: Ingredients in formulations.
- Personal Care: Chelating agents, stabilizers, pH adjusters, surfactants.
- Metallurgy: Refining agents, complexing agents, fluxing agents, corrosion inhibitors.
- Animal Health: Excipients, stabilizers, preservatives, buffering agents.
- Manufacturing Excellence:
- Custom Manufacturing: Tailored to achieve high purity levels specified by clients, requiring deep domain knowledge and expertise.
- Quality Standards: Adherence to both domestic and international standards, ensuring product quality and consistency.
- Research and Development:
- In-House RDT Laboratory: Equipped with advanced equipment and systems for developing new products and testing against industry standards.
- RDT Team: Comprising 16 science graduates and post-graduates dedicated to ensuring product quality and innovation..
- Certifications and Standards:
- Products conform to various stringent industry standards like IP, BP, EP, JP, USP, FCC, LR, AR, GR, and ACS.
- Custom manufacturing capabilities to meet unique customer specifications beyond standard requirements.
Objects of the Issue
- Carry out the Offer for Sale of up to 95,70,000 Equity Shares aggregating up to ₹ 130.15 crore by the Promoter Selling Shareholders
- Achieve the benefits of listing the Equity Shares on the Stock Exchanges.
IPO Details
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
| Fields | Details |
|---|---|
| IPO Dates | 03 Jun - 05 Jun 2024 |
| IPO Price Band | ₹ 129 – 136 per share |
| Fresh Issue | NA |
| Offer For Sale | Up to 95,70,000 shares |
| Total IPO Size | Approx ₹ 130.15 crore |
| Face Value | ₹ 10 |
| Listing On | BSE, NSE |
IPO Timeline
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
| Event | Date |
|---|---|
| IPO Opening Date | 03 Jun 2024 |
| IPO Closing Date | 05 Jun 2024 |
| Basis Of Allotment | 06 Jun 2024 |
| Refunds | 07 Jun 2024 |
| Demat Transfer | 07 Jun 2024 |
| IPO Listing Date | 10 Jun 2024 |
Financial Statements
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
| Period Ended | 31st March 2021 | 31st March 2022 | 31st March 2023 | Dec 2023 |
|---|---|---|---|---|
| Total Income | 63.24 | 83.34 | 97.50 | 68.44 |
| Total Expenses | 50.02 | 64.99 | 75.17 | 48.23 |
| Net Profit/Loss | 9.73 | 13.63 | 16.62 | 15.47 |
| NPM (*) | 15.39 | 16.35 | 17.04 | 22.60 |
| Total Assets | 37.65 | 56.79 | 54.03 | 66.96 |
| Total Liabilities | 10.83 | 16.44 | 9.36 | 6.68 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Valuation
Uncover significant valuation metrics such as EPS (Earnings Per Share), ROE (Return on Equity), ROCE (Return on Capital Employed), D/E Ratio (Debt-to-Equity Ratio), Current Ratio, and EBITDA Margin. These key indicators offer insights into the company's financial standing and performance, aiding in informed investment decisions.
| Period Ended | 31st March 2021 | 31st March 2022 | 31st March 2023 | Dec 2023 |
|---|---|---|---|---|
| EPS | 2.40 | 3.49 | 4.30 | 4.17 |
| ROE (%) | 36.29 | 33.77 | 37.19 | 25.66 |
| ROCE (%) | 51.78 | 46.27 | 49.86 | 33.15 |
| D/E Ratio | Negligible | 0.02 | NA | NA |
| Current Ratio | 3.30 | 3.21 | 3.85 | 6.05 |
| EBITDA MARGIN (%) | 23.70 | 23.95 | 23.01 | 30.23 |
* Compiled from DRHP/RHP for valuation purposes.
Peer Comparison
Compare key financial metrics with industry peers to gain valuable insights into the company's performance compared to its competitors.
| Name | Revenue | P/E | EPS | RoNW | NAV |
|---|---|---|---|---|---|
| Kronox Lab Sciences Limited | 67.69 | 31.63 | 4.30 | 37.19 | 12.04 |
| Tatva Chintan Pharma Chem Limited | 295.24 | 57.57 | 19.45 | 8.84 | 220.07 |
| Tanfac Industries Limited | 275.34 | 39.15 | 56.27 | 30.46 | 184.74 |
| Neogen Chemicals Limited | 491.02 | 77.55 | 18.94 | 10.36 | 182.90 |
| Sigachi Industries Limited | 294.83 | 46.64 | 1.42 | 16.22 | 8.73 |
| DMCC Speciality Chemical Limited | 242.64 | 116.57 | 2.78 | 3.50 | 79.49 |
* Revenue in (₹cr), RoNW in (%), EPS, NAV in (₹). P/E ratio is based on the highest price from the IPO price band.
Subscription Data from NSE and BSE
| Investor Type | Subscribed |
|---|---|
| Qualified Institutional Buyer (QIB) | 89.03 |
| Non-Institutional Investor (NII/HNI) | 301.92 |
| Retail Individual Investor (RII) | 54.24 |
| Total | 117.25 |
* All figures represent multiples of the subscription. Check subscriptions for other ongoing issues here.
IPO Registrar
KFin Technologies Limited
Phone: +91 40 6716 2222/ 18003094001
Email: einward.ris@kfintech.com
Website: www.kfintech.com
Company Promoters
- JOGINDERSINGH JASWAL
- KETAN RAMANI
- PRITESH RAMANI
Lead Managers
- Pantomath Capital Advisors Private Limited
Company Address
Kronox Lab Sciences Limited
Block No. 353, Village Ekalbara, Padra, Vadodara 391 440, Gujarat, India
Phone: +91 26 6224 4077/88
Email: cs@kronoxlabsciences.com
Website: www.kronoxlabsciences.com
FAQs
- What is the issue size of the Kronox Lab Sciences IPO?The Kronox Lab Sciences IPO has an issue size of Approx ₹ 130.15 crore. This includes a fresh issue of NA and an offer for sale (OFS) of Up to 95,70,000 shares.
- What is the price band of the Kronox Lab Sciences IPO?The price band for the Kronox Lab Sciences IPO is ₹ 129 – 136 per share.
- What are the bidding dates for the Kronox Lab Sciences IPO?The Kronox Lab Sciences IPO will open for bidding on 03 Jun 2024 and close on 05 Jun 2024.
- What is the allotment date for the Kronox Lab Sciences IPO?The allotment date for the Kronox Lab Sciences IPO is 06 Jun 2024.
- What is the listing date for the Kronox Lab Sciences IPO?The listing date for the Kronox Lab Sciences IPO is 10 Jun 2024.
- What is the Kronox Lab Sciences IPO grey market premium?The grey market premium (GMP) for the Kronox Lab Sciences IPO is currently at ₹28, with an expected listing gain of approximately 20.59%. Remember, the grey market premium is not an official indicator, but it reflects market perception and demand for the IPO shares.